Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-3948
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sustained absorption of delamanid from lipid-based formulations as a path to reduced frequency of administration ; day:15 ; month:9 ; year:2020 ; pages:1-9
Drug Delivery and Translational Research ; (15.9.2020), 1-9
- Urheber
-
Ramirez, Gisela
Pham, Anna C.
Clulow, Andrew J.
Salim, Malinda
Hawley, Adrian
Boyd, Ben J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-020-00851-z
- URN
-
urn:nbn:de:101:1-2020110322115804778882
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ramirez, Gisela
- Pham, Anna C.
- Clulow, Andrew J.
- Salim, Malinda
- Hawley, Adrian
- Boyd, Ben J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Field measurements of water continuum and water dimer absorption by active long path differential optical absorption spectroscopy (DOAS)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations
Field measurements of water continuum and water dimer absorption by active long path differential optical absorption spectroscopy (DOAS)
Comparative absorption of curcumin formulations
Development of sustained release formulations for phytopharmaceuticals
Sustained release formulations for compounds underlying intestinal drug efflux
Sustained release formulations for compounds underlying intestinal drug efflux
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Crystalline monoclonal antibodies : development of stable crystals for drying and sustained release formulations
Crystalline Monoclonal Antibodies: Development of stable crystals for drying and sustained release formulations
Development of sustained release formulations for the intra-articular delivery of a therapeutic antibody
Pharmacokinetics of Ambroxol Sustained Release (Mucosolvan® Retard) Compared with Other Formulations in Healthy Volunteers
Comparison of nitrous acid detection using open-path incoherent broadband cavity-enhanced absorption spectroscopy and extractive long-path absorption photometry
Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations